Biotech
Israeli mathematician uses AI to decode human immune system
How an Israeli mathematician is using AI to decode the human immune system and transform patient treatment
Israel's overlooked challenge: Environmental damage from two years of war - from the editor
Immunai, Bristol Myers Squibb sign AI immune-data collaboration
Israeli researchers develop SafeWax coating that could cut pesticide use by 50%
Israel’s cell-based coffee: Sustainable solution to brewing industry challenges?
Due to climate change, within the next two decades, there is an expected 50% reduction in areas suitable for growing coffee.
Profuse Technology achieves 80% faster muscle growth for cultivated meat
A cultivated meat company has developed a new method for promoting muscle growth in the lab • the new technique enhances protein content by a factor of five, with tissue reaching maturity in just 48h
Innovation Authority puts NIS 113 million toward Bio-Convergence development
The move is a significant step forward in Israel's goal of becoming a global leader in the bio-convergence field.
IL MAKIAGE invests in the future of AI cosmetics
TAU Prof. Dan Peer appointed as member of American National Academy of Engineering
The National Academy of Engineering (NAE),has announced the appointment of Prof. Dan Peer from TAU as a Member of the Academy, in recognition of his groundbreaking research.
Biomica raises $20m. to advance pipeline of microbiome-based therapeutics
The financing round will be led by Shanghai Healthcare Capital, meaning it's subject to the clearance of Chinese regulatory authorities.
Israel develops cutting edge medication technology
The research was led by doctoral student Itai Katzir and supervised by Dr. Ayala Lampel from TAU’s Shmunis School of Biomedicine and Cancer Research at the Wise Faculty of Life Sciences.
New at-home brain monitoring solution launched by X-trodes, Emotiv
The collaboration pairs X-trodes’ wearable sensing technology with EmotivPRO, EMOTIV’s EEG data platform for neuroscience research.
Israeli breakthrough company seeks to use cells to improve quality of life
The biotechnology company Pluri, is expanding its activities and establishing strategic collaborations for the development and marketing of food-tech and pharmaceutical products.
EU regulator backs two Omicron-adapted COVID boosters
Developed by Moderna and the team of Pfizer and BioNTech, the new so-called bivalent shots combat the BA.1 version of Omicron and the original virus first detected in China.
